Apolipoprotein B:: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis

被引:227
作者
Olofsson, SO [1 ]
Borèn, J [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Univ Hosp, Wallenberg Lab Cardiovasc Res, SE-41345 Gothenburg, Sweden
关键词
apolipoproteins B; atherosclerosis; proteoglycans; very low-density lipoprotein assembly; very low-density lipoproteins;
D O I
10.1111/j.1365-2796.2005.01556.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apolipoprotein (apo) B exists in two forms apoB100 and apoB48. ApoB100 is present on very low-density lipoproteins (VLDL), intermediate density lipoproteins (IDL) and LDL. ApoB100 assembles VLDL particles in the liver. This process starts by the formation of a pre-VLDL, which is retained in the cell unless converted to the triglyceride-poor VLDL2. VLDL2 is secreted or converted to VLDL1 by a bulk lipidation in the Golgi apparatus. ApoB100 has a central role in the development of atherosclerosis. Two proteoglycan-binding sequences in apoB100 have been identified, which are important for retaining the lipoprotein in the intima of the artery. Retention is essential for the development of the atherosclerotic lesion.
引用
收藏
页码:395 / 410
页数:16
相关论文
共 114 条
[1]   Apolipoprotein B is intracellularly associated with an ER-60 protease homologue in HepG2 cells [J].
Adeli, K ;
Macri, J ;
Mohammadi, A ;
Kito, M ;
Urade, R ;
Cavallo, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (36) :22489-22494
[2]   Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia [J].
Adiels, M ;
Borén, J ;
Caslake, MJ ;
Stewart, P ;
Soro, A ;
Westerbacka, J ;
Wennberg, B ;
Olofsson, SO ;
Packard, C ;
Taskinen, MR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) :1697-1703
[3]   A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions [J].
Adiels, M ;
Packard, C ;
Caslake, MJ ;
Stewart, P ;
Soro, A ;
Westerbacka, J ;
Wennberg, B ;
Olofsson, SO ;
Taskinen, MR ;
Borén, J .
JOURNAL OF LIPID RESEARCH, 2005, 46 (01) :58-67
[4]   Checkpoints in ER-associated degradation: excuse me, which way to the proteasome? [J].
Ahner, A ;
Brodsky, JL .
TRENDS IN CELL BIOLOGY, 2004, 14 (09) :474-478
[5]   SUBCELLULAR-LOCALIZATION OF B APOPROTEIN OF PLASMA LIPOPROTEINS IN RAT-LIVER [J].
ALEXANDER, CA ;
HAMILTON, RL ;
HAVEL, RJ .
JOURNAL OF CELL BIOLOGY, 1976, 69 (02) :241-263
[6]   Activation of peroxisome proliferator-activated receptor α increases the expression and activity of microsomal triglyceride transfer protein in the liver [J].
Améen, C ;
Edvardsson, U ;
Ljungberg, A ;
Asp, L ;
Åkerblad, P ;
Tuneld, A ;
Olofsson, SO ;
Lindén, D ;
Oscarsson, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (02) :1224-1229
[7]   Molecular mechanisms of apolipoprotein B mRNA editing [J].
Anant, S ;
Davidson, NO .
CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (02) :159-165
[8]   ADP-ribosylation factor 1 and its activation of phospholipase D are important for the assembly of very low density lipoproteins [J].
Asp, L ;
Claesson, C ;
Borén, J ;
Olofsson, SO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) :26285-26292
[9]   Role of ADP ribosylation factor 1 in the assembly and secretion of ApoB-100-containing lipoproteins [J].
Asp, L ;
Magnusson, B ;
Rutberg, M ;
Li, L ;
Borén, J ;
Olofsson, SO .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (03) :566-570
[10]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917